These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

982 related items for PubMed ID: 19422869

  • 1. siRNA delivery systems for cancer treatment.
    Oh YK, Park TG.
    Adv Drug Deliv Rev; 2009 Aug 10; 61(10):850-62. PubMed ID: 19422869
    [Abstract] [Full Text] [Related]

  • 2. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A.
    Curr Opin Mol Ther; 2007 Aug 10; 9(4):345-52. PubMed ID: 17694447
    [Abstract] [Full Text] [Related]

  • 3. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD, Huang L.
    Curr Opin Investig Drugs; 2008 Dec 10; 9(12):1317-23. PubMed ID: 19037838
    [Abstract] [Full Text] [Related]

  • 4. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK, Hajeri PB.
    Drug Discov Today; 2009 Sep 10; 14(17-18):859-65. PubMed ID: 19540929
    [Abstract] [Full Text] [Related]

  • 5. Small interfering RNA for experimental cancer therapy.
    Tong AW, Zhang YA, Nemunaitis J.
    Curr Opin Mol Ther; 2005 Apr 10; 7(2):114-24. PubMed ID: 15844618
    [Abstract] [Full Text] [Related]

  • 6. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L, Charnet A, Morris MC, Aldrian-Herrada G, Heitz F, Divita G.
    Biochem Soc Trans; 2007 Feb 10; 35(Pt 1):44-6. PubMed ID: 17233597
    [Abstract] [Full Text] [Related]

  • 7. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.
    Reischl D, Zimmer A.
    Nanomedicine; 2009 Mar 10; 5(1):8-20. PubMed ID: 18640078
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
    Gary DJ, Puri N, Won YY.
    J Control Release; 2007 Aug 16; 121(1-2):64-73. PubMed ID: 17588702
    [Abstract] [Full Text] [Related]

  • 10. RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics.
    de Fougerolles A, Manoharan M, Meyers R, Vornlocher HP.
    Methods Enzymol; 2005 Aug 16; 392():278-96. PubMed ID: 15644187
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. On the delivery of small interfering RNAs into mammalian cells.
    Sioud M.
    Expert Opin Drug Deliv; 2005 Jul 16; 2(4):639-51. PubMed ID: 16296791
    [Abstract] [Full Text] [Related]

  • 14. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
    Vorhies JS, Nemunaitis J.
    Expert Rev Anticancer Ther; 2007 Mar 16; 7(3):373-82. PubMed ID: 17338656
    [Abstract] [Full Text] [Related]

  • 15. Short interfering RNA (siRNA): tool or therapeutic?
    Cejka D, Losert D, Wacheck V.
    Clin Sci (Lond); 2006 Jan 16; 110(1):47-58. PubMed ID: 16336204
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhalable siRNA: potential as a therapeutic agent in the lungs.
    Durcan N, Murphy C, Cryan SA.
    Mol Pharm; 2008 Jan 16; 5(4):559-66. PubMed ID: 18491918
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, Hellaudais L, Bieth A, Pillaire MJ, Cazaux C, Hoffmann JS, Couderc B, Teissié J.
    Gene Ther; 2007 May 16; 14(9):752-9. PubMed ID: 17344906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.